Feasibility Assessment of Chemical Testing for Drug Impairment: Final Report
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Feasibility Assessment of Chemical Testing for Drug Impairment: Final Report

Filetype[PDF-2.56 MB]


English
Details You May Also Like

Details:

  • Creators:
    Willette, Robert E.
  • Corporate Creators:
    Duo Research
  • Corporate Contributors:
    United States. National Highway Traffic Safety Administration
  • Subject/TRT Terms:
  • Publication/ Report Number:
  • DOI:
  • Resource Type:
    Research Paper
  • Geographical Coverage:
    United States
  • Corporate Publisher:
    United States. National Highway Traffic Safety Administration
  • Abstract:
    An evaluation was made of existing data on concentrations of marijuana, secobarbital, diazepam, diphenhydramine, and methaqualone in blood, saliva and urine to assess the feasibility of establishing chemical teats for detecting drug-impaired driving. The study employed standard pharmacokinetic methods to relate urine and saliva concentrations to blood levels, which were related to measures of behavioral impairment in laboratory tasks. Marijuana was the only drug for which sufficient data were available to suggest the use of urine tests to establish the need to obtain or analyze a blood specimen for THC. Data from numerous studies support the proposal that testing for THC metabolites in urine at or above the 100 ng/ml concentration will provide better than a 50% probability of detecting levels of THC in the blood that may be associated with impairment. Saliva appears to offer more promise as a body specimen for a presumptive screen of the other drugs included in the study. Analysis of data on secobarbital, as a representative of the barbiturate group of sedatives, suggested saliva concentrations in excess of 0.5 ug/ml may serve as a possible threshold for predicting impairing levels of the drug in the blood. Similarly, a combined concentration of 5 ng/ml of diazepam and its primary metabolite in saliva appeared as a reasonable level. The antihistamine dipehenhydramine gives high saliva concentrations following its use, thus level of 180 ng/ml in saliva was selected as a threshold for conducting a blood analysis. Evaluation of data on methaqualone suggests a threshold level of 150 ng/ml in saliva. It is cautioned that this was a preliminary study based on existing data. Additional studies and collection of more prevelance data are necessary to further establish the reliability of the suggested threshold levels in order to predict when blood tests for a specific drug are necessary or desirable. Such tests are presently only available for alcohol and marijuana with use limited to the stationhouse or emergency room. At the present state of knowledge, blood is the only body fluid that may serve in a limited manner to relate drug levels to impaired driving. /Abstract from report summary page/
  • Format:
    PDF
  • Funding:
    DTNH-22-84-C-07265
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at rosap.ntl.bts.gov